Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
about
Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?NT5E mutations that cause human disease are associated with intracellular mistrafficking of NT5E proteinIntegrins, myofibroblasts, and organ fibrosis.Telocytes in human liver fibrosis.Establishment and characterization of rat portal myofibroblast cell lines.Chronic restraint stress decreases the repair potential from mesenchymal stem cells on liver injury by inhibiting TGF-β1 generation.Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion.Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells.The portal fibroblast: not just a poor man's stellate cell.The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.Portal Fibroblasts in Biliary FibrosisHuman liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts.Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.Epithelial-mesenchymal transition in liver fibrosisFibroblast-Extracellular Matrix Interactions in Tissue FibrosisGlial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C InfectionAn Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts.Test of Antifibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients.Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.
P2860
Q28084572-CEAF3B8F-C9B2-4308-A25C-CABDAF6E5530Q28539242-C7A55700-09E7-4A0F-B7DE-F2321572C369Q33946587-60A9EED1-867F-44A4-9C63-FD04DD64BDFEQ35206538-82D5DEB9-EE34-44BE-B7CC-4463C85C4B97Q35589905-DB9B2DF5-7F5D-41CB-A0BD-868DE118FF04Q36179620-675841BD-9CC8-4584-B0D5-A972B93BE878Q36218507-9961F32F-1CC2-45C9-8D70-C441C352E832Q37214779-82E6D5B3-A432-4DD5-9029-0213E92FAEABQ38210738-BCCAD943-28F9-4CD5-84D8-911CCF4E48FDQ38237634-8FBC4F6A-EFD5-41FB-93D1-AB4F967E0AA8Q38322997-5F06DC21-13FB-4EFC-BF20-2AFC4764F321Q38544274-AFC5BF46-737C-4F75-B218-59E463D1AB0AQ38603748-4B31A8E9-8BFF-42D5-8527-8EBCC8B11C97Q38718014-AABE2733-1E72-4713-973F-B7B3B7646BF5Q41151245-1E38E306-D523-4BF5-801F-E037415B900FQ41737712-DB2AF948-6B15-4640-B534-B872A3822602Q46341987-B43E7C68-219B-4DB1-9D68-DAACA5302A9CQ50079567-F364213D-B102-480B-B3EE-A5DDC164E652Q51144706-21C2BC13-A28E-479B-9D01-BB10294247C0Q52729640-6AF80C3C-EDFC-4C40-8C1D-8352BC80DA1BQ53381128-6EC2A0DE-2FE0-48DE-876D-0D5A91AB5384
P2860
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
@en
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.
@nl
type
label
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
@en
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.
@nl
prefLabel
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
@en
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.
@nl
P2093
P2860
P1476
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
@en
P2093
Elise G Lavoie
Jonathan A Dranoff
Michel Fausther
P2860
P2888
P304
P356
10.1007/S40139-013-0020-0
P577
2013-09-01T00:00:00Z